ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 761

$604K Total Retail Price of All Prescriptions

Rank: 72 out of 761

559 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,669 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 523 469 1 3
AMLODIPINE BESYLATE 442 365 2 6
SIMVASTATIN 361 335 3 2
OMEPRAZOLE 329 285 4 4
FUROSEMIDE 324 274 5 7
LISINOPRIL 312 271 6 1
POTASSIUM CHLORIDE 302 262 7 18
ATENOLOL 267 247 8 8
SERTRALINE HCL 217 206 9 25
GABAPENTIN 204 159 10 15
PRAVASTATIN SODIUM 167 142 11 20
LOSARTAN POTASSIUM 166 152 12 13
ATORVASTATIN CALCIUM 164 145 13 12
TRAZODONE HCL 144 140 14 23
TAMSULOSIN HCL 138 138 15 27
METFORMIN HCL 130 116 16 10
DONEPEZIL HCL 128 117 17 33
HYDROCODONE-ACETAMINOPHEN 127 116 S3 18 5
ZOLPIDEM TARTRATE 122 111 19 22
PREDNISONE 121 113 20 30
METOPROLOL TARTRATE 108 105 21 14
NAMENDA 105 105 22 59
CARVEDILOL 104 100 23 26
TRIAMTERENE-HCTZ 102 86 24 42
HYDROCHLOROTHIAZIDE 99 95 25 11
FLUTICASONE PROPIONATE 91 83 26 29
LOVASTATIN 91 79 26 17
RANITIDINE HCL 89 57 28 52
POLYETHYLENE GLYCOL 3350 86 62 29 62
ADVAIR DISKUS 83 73 30 37
FINASTERIDE 80 75 31 73
CITALOPRAM HBR 78 71 32 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 63 33 35
METOPROLOL SUCCINATE 76 64 34 16
OXYCODONE HCL 72 59 S2 35 24
INSULIN SYRINGE 68 52 36 78
AMLODIPINE BESYLATE-BENAZEPRIL 67 64 37 157
QUETIAPINE FUMARATE 65 56 38 90
ROPINIROLE HCL 63 52 39 95
AGGRENOX 61 61 40 121
BUSPIRONE HCL 60 52 41 154
PAROXETINE HCL 58 40 42 47
LANTUS 57 40 43 41
NISOLDIPINE 56 56 44 266
GLIMEPIRIDE 56 50 44 48
KLOR-CON 10 56 42 44 74
TRAMADOL HCL 54 46 47 34
METFORMIN HCL ER 53 39 48 67
WARFARIN SODIUM 52 52 49 9
TERAZOSIN HCL 52 52 49 86
PROAIR HFA 51 27 51 32
CYMBALTA 51 44 51 53
PROPRANOLOL HCL 51 39 51 100
CARBIDOPA-LEVODOPA 51 51 51 82
VERAPAMIL ER 50 44 55 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.